SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX) and United Kingdom-based Bio-Genesys Diagnostics announced that they have entered a partnership to offer commercial genotyping services. Under the terms of the agreement, the genetic testing services offered by Bio-Genesys Diagnostics for cattle, pigs, goats, sheep, and camelids will be run exclusively on Affymetrix’s technology. The partnership […]

SANTA CLARA, Calif. — Affymetrix, Inc. (NASDAQ:AFFX) is introducing several new agrigenomic genotyping solutions this week at the annual Plant and Animal Genome Conference (PAG XXIV). Following the company’s acquisition of Eureka Genomics in mid-2015, Affymetrix is introducing Eureka™ Genotyping Solution for low-cost, low-plex genotyping by sequencing (GBS). The company is also introducing two new […]

Epigenomics, the MEDLINE-indexed journal published by Future Science Group, is excited to announce the publication of the first study validating the MethylationEPIC BEadChip microarray – the new and improved DNA methylation array from Illumina (CA, USA). The validation of this array provides the research community with a powerful new method for elucidating the role of […]

Oxford and Cambridge, UK – Oxford Gene Technology (OGT), the molecular genetics company, has continued its impressive sales performance and has refocused its business to take advantage of the significant growth potential in the global genomics market. Commercial and financial highlights for the year ended 30 September show the company delivering £14.3m sales revenues on […]

SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX) introduces Axiom® Turkey Genotyping Array, developed in collaboration with the United States Department of Agriculture – Agricultural Research Service (USDA-ARS) along with Aviagen and Hendrix Genetics. The array will help breeders better understand the genetics of turkeys in order to improve meat characteristics and health. It will […]

Oxford, UK – Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. This novel technology overcomes the limitations of restriction enzyme-based SNP probe approaches previously employed at BMGL for loss of heterozygosity […]

SAN DIEGO – Illumina (Nasdaq:ILMN) today announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The company also announced the completion of the […]

SANTA CLARA, Calif. & HALIFAX, Nova Scotia — Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc., a direct-to-consumer sports genetics company, today announced a global partnership agreement. Under the agreement, Athletigen will use Affymetrix Axiom® genotyping platform for its sports-related DNA analysis service. DNA from a saliva sample will be genotyped using Athletigen’s DNA microarray […]

LGC is delighted to have been appointed as TraitGenetics’ Global Distribution Partner for its array based SNP genotyping services. The agreement permits TraitGenetics to keep direct links to many customers while extending its reach especially to customers outside of Europe. This agreement will see LGC offer array based SNP genotyping (Illumina and Affymetrix) from TraitGenetics […]